Tennis Star Aryna Sabalenka Takes Stake In David Beckham’s Im8 

Sabalenka is now a global ambassador and shareholder of IM8, one of the world’s fastest-growing supplement brands

IM8, the supplement brand co-founded by David Beckham and health sciences company Prenetics, has signed female tennis star Aryna Sabalenka as a global ambassador in a deal that also sees Sabalenka become a shareholder of IM8, the sides announced during Wimbledon 2025.

The deal marks the first time Sabalenka, currently the top-ranked player in women’s tennis, has endorsed a supplement brand. According to the sides, the partnership came about organically after Sabalenka started using IM8 at the urging of her coach earlier this year and saw results.

“As a professional athlete, I’m extremely cautious about what I put in my body. I’ve tried countless supplements and naturally am always skeptical. Trust is everything,” Sabalenka said in a statement. “After my coach recommended IM8, I noticed a difference within weeks – better energy throughout long matches, faster recovery, and improved focus when it matters most.” 

She added that the partnership goes “far beyond a typical endorsement.” 

“I’ve become a shareholder in Prenetics because I genuinely believe in what this product delivers,” Sabalenka said. “Being part of a brand co-founded by David Beckham, who understands the demands of elite sports at the highest level, makes this even more special.” 

As a global ambassador, Sabalenka will become “another face of the brand” for IM8 alongside Beckham, Prenetics CEO Danny Yeung told Athletech News. For example, Sabalenka will feature prominently on the homepage of IM8’s website, which until now has been adorned exclusively by Beckham.

Beckham will continue to feature in marketing for IM8, but the addition of Sabalenka gives IM8 an impressive one-two punch of globally popular sports figures, including a current female star. 

IM8 made a big push into the U.S. market earlier this year, but Yeung notes that it’s a global brand with global ambitions.

“The U.S. market only makes up 50% of our overall sales,” he said. “So having someone like (Sabalenka) who is at the peak of her game – a world number one – will introduce us to a lot more customers, and I’d imagine a lot of athletes as well.” 

Betting Big on Science-Backed Wellness

Officially launched in November, IM8 offers two products: “Daily Ultimate Essentials,” a supplement powder that acts as a multivitamin, probiotic and more all wrapped into one, and “Daily Ultimate Longevity,” an anti-aging pill (later this year, the company plans to introduce a powder version of the longevity pill).

Marketed as an all-in-one supplement that replaces the need for 16 daily supplements, Daily Ultimate Essentials contains vitamins and minerals, probiotics, prebiotics and postbiotics, along with ingredients designed to support an array of positive health outcomes like energy, cognitive function, gut health and hydration. 

Looking to be known as more than just a celebrity-backed supplement brand, IM8 has leaned heavily into science-backed marketing, touting the quality of its ingredients and the presence of a scientific advisory board, a group of doctors, researchers and scientists who’ve informed the brand on product formulation. The brand’s products have also been Certified for Sport by NSF, a not-for-profit organization that tests supplements for harmful substances.

IM8 also has affiliations with well-known doctors and nutritionists including Dr. Jeremy London, a cardiovascular surgeon with 1.3 million followers on Instagram, and Simon Hill, a nutritionist with over 1 million followers. 

So far, the strategy appears to be working. Earlier this month, Prenetics released Q1 figures showing that IM8 had more than 55,000 customers across 31 countries, the vast majority of whom subscribe to receive supplements monthly. The brand did $5.7 million in revenue in the first quarter of this year, making up a significant chunk of Prenetics’ overall business. As sales accelerate, Prenetics estimates that the Beckham-backed supplement brand will reach around $8.5 million in revenue in Q2 of this year. 

“By the end of the year, it’s quite realistic that we’ll have more than 100,000 customers,” Yeung projected, noting that the brand is experiencing double-digit month-over-month growth. 

“Our goal is that in a few years, millions of people are going to be taking IM8 on a daily basis,” he added. 

The post Tennis Star Aryna Sabalenka Takes Stake in David Beckham’s IM8  appeared first on Athletech News.